Showing results (41-50 of 379) with videos related to
Sort By:
Pageof 38
Inflammatory Bowel Diseases|January 10, 2001
Familial and sporadic inflammatory bowel disease: different entities?M Peeters, A Cortot, S Vermeire, et al.Alimentary Pharmacology & Therapeutics|May 4, 2018
Systematic review: safety of mesalazine in ulcerative colitisP Sehgal, J-F Colombel, A Aboubakr, et al.Journal of Endodontics|February 25, 2000
Bacterial microleakage of Cavit, IRM, TERM, and Fermit: a 21-day in vitro studyE Deveaux, P Hildelbert, C Neut, et al.Gastroenterology|February 1, 1992
Acute exposure of small intestine to ethanol induces mucosal leakage and prostaglandin E2 synthesisB Lavö, J F Colombel, L Knutsson, et al.The American Review of Respiratory Disease|August 1, 1991
Human alveolar macrophage antibacterial activity in the alcoholic lungB Wallaert, C Aerts, J F Colombel, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2003
In vitro activity of gatifloxacin, a new fluoroquinolone, against 204 anaerobes compared to seven other compoundsL Dubreuil, J Behra-Miellet, C Neut, et al.Biomaterials|January 1, 1992
In vitro effects of titanium powder on oral bacteriaK Elagli, C Neut, C Romond, et al.European Journal of Human Genetics : EJHG|June 3, 1999
Detailed transcript map of a 810-kb region at 11p14 involving identification of 10 novel human 3' exonsF Guillemot, C Auffray, M D DevignesGut|May 16, 2006
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implicationsJ Satsangi, M S Silverberg, S Vermeire, et al.Alimentary Pharmacology & Therapeutics|February 16, 2011
Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experienceS Danese, J-F Colombel, W Reinisch, et al.Pageof 38